全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

下肢深静脉血栓患者血脂的表达水平及其临床意义分析
Analysis of the Expression Levels of Lipids and Their Clinical Significance in Patients with Lower Extremity Deep Vein Thrombosis

DOI: 10.12677/ACM.2024.141108, PP. 774-780

Keywords: 下肢静脉血栓,高密度脂蛋白,血脂水平
Lower Extremity Venous Thrombosis
, HDL, Lipid Levels

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的:探讨血脂水平与下肢深静脉血栓(DVT)之间潜在临床意义。方法:研究纳入204例研究对象,包括104名DVT患者和100名非DVT患者。本研究收集了两组患者的年龄、性别,体重指数(BMI)、吸烟史、现病史、既往史等基本信息,高密度脂蛋白(HDL)、低密度脂蛋白(LDL)、甘油三酯(TG)、总胆固醇(TC)、载脂蛋白A1 (APOA1)、载脂蛋白B (APOB)等血脂指标的结果,以及活化部分凝血活酶时间(APTT)、凝血活酶时间(TT)、凝血酶原时间(PT)、纤维蛋白原(FIB)等凝血指标的结果。应用多变量回归分析,对两组研究对象进行分析。在本研究中,我们特别关注血脂水平与DVT之间的潜在联系。结果:64岁及以下的人群HDL、TG值和两年龄组的APOA1值与患DVT有关(P < 0.05)。其中,64岁及以下的人群中较高的HDL值和两年龄组较高的APOA1值是患DVT的保护因素,即该年龄段的HDL和AOPA1值越高,患DVT的可能性越小。64岁及以下人群较高的TG值是患DVT的危险因素,即TG值越高,该人群患DVT的可能性越高。结论:研究认为HDL水平降低增加了DVT发生的风险,同时APOA1值也是患DVT的保护因素,即高APOA1与DVT风险降低有关,此外TG值是患DVT的危险因素。
Objective: To investigate the potential clinical significance of the relationship between lipid levels and lower extremity deep vein thrombosis (DVT). Methods: The study encompassed 204 partici-pants, consisting of 104 individuals diagnosed with DVT and 100 non-DVT subjects. We meticulous-ly collected and analyzed essential demographic details, including age, gender, body mass index (BMI), smoking history, current medical conditions, and medical history. Additionally, we obtained lipid profile data, encompassing high-density lipoprotein (HDL), low-density lipoprotein (LDL), tri-glycerides (TG), total cholesterol (TC), apolipoprotein A1 (APOA1), and apolipoprotein B (APOB). Furthermore, we measured coagulation parameters, including activated partial thromboplastin time (APTT), thromboplastin time (TT), prothrombin time (PT), fibrinogen (FIB), and other coagu-lation indices. We employed a robust multivariate regression analysis to scrutinize the data from the two distinct study groups. Our primary focus was on identifying potential associations between lipid levels and the incidence of DVT. Results: Levels of HDL and TG in the population aged 64 and below, and the level of APOA in both age groups are associated with the risk of DVT (P < 0.05). Among them, higher HDL values in those aged 64 years and younger and higher APOA1 values in both age groups were protective factors for DVT, meaning that the higher the HDL and AOPA1 val-ues in that age group, the less likely they were to suffering from DVT. Higher TG values in people aged 64 years and younger are a risk factor for DVT, meaning that the higher the TG value, the higher the probability of developing DVT in that group of people. Conclusion: It was concluded that lower HDL levels increased the risk of developing DVT, as well as APOA1 values were protective fac-tors for developing DVT, that is, high APOA1 was associated with a reduced risk of DVT, in addition to TG values being a risk factor for developing DVT.

References

[1]  Khan, F., Tritschler, T., Kahn, S.R. and Rodger, M.A. (2021) Venous Thromboembolism. The Lancet, 398, 64-77.
https://doi.org/10.1016/S0140-6736(20)32658-1
[2]  Cheuk, B.L.Y., Cheung, G.C.Y. and Cheng, S.W.K. (2004) Epidemiology of Venous Thromboembolism in a Chinese Population. British Journal of Surgery, 91, 424-428.
https://doi.org/10.1002/bjs.4454
[3]  Cohen, A.T., Hamilton, M., Bird, A., et al. (2017) Comparison of the Non-Vka Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Ve-nous Thromboembolism: Systematic Review and Network Meta-Analysis. PLOS ONE, 11, e0160064.
https://doi.org/10.1371/journal.pone.0160064
[4]  Hu, M., Li, X. and Yang, Y. (2023) Causal Associations be-tween Cardiovascular Risk Factors and Venous Thromboembolism. Seminars in Thrombosis and Hemostasis, 49, 679-687.
https://doi.org/10.1055/s-0042-1760335
[5]  Poredos, P. (2017) Interrelationship between Venous and Arterial Thrombosis. International Angiology, 36, 295-298.
[6]  Camilleri, E., van Rein, N., van Vlijmen, B.J.M., et al. (2023) Influence of Rosuvastatin on Apolipoproteins and Coagulation Factor Levels: Results from the Statin Reduce Thrombophilia Trial. Research and Practice in Thrombosis and Haemostasis, 7, Article ID: 100063.
https://doi.org/10.1016/j.rpth.2023.100063
[7]  Van Schouwenburg, I., Mahmoodi, B., Gansevoort, R., et al. (2012) Lipid Levels Do Not Influence the Risk of Venous Thromboembolism. Results of a Population-Based Cohort Study. Thrombosis and Haemostasis, 108, 923-929.
https://doi.org/10.1160/TH12-06-0426
[8]  李晓强, 张福先, 王深明. 深静脉血栓形成的诊断和治疗指南(第三版) [J]. 中国血管外科杂志(电子版), 2017, 9(4): 250-257.
[9]  李杨. 彩色多普勒超声诊断下肢深静脉血栓的临床价值分析[J]. 智慧健康, 2023, 9(12): 5-8.
https://doi.org/10.19335/j.cnki.2096-1219.2023.12.002
[10]  Heit, J.A., Spencer, F.A. and White, R.H. (2016) The Epidemiology of Venous Thromboembolism. Journal of Thrombosis and Thrombolysis, 41, 3-14.
https://doi.org/10.1007/s11239-015-1311-6
[11]  Cheng, X., Fan, L., Hao, J., et al. (2022) Red Cell Distribution Width-to-High-Density Lipoprotein Cholesterol Ratio (RHR): A Promising Novel Predictor for Preoperative Deep Vein Thrombosis in Geriatric Patients with Hip Fracture. Clinical Interventions in Aging, 17, 1319-1329.
https://doi.org/10.2147/CIA.S375762
[12]  Luscher, T.F., Landmesser, U., Von Eckardstein, A. and Fogelman, A.M. (2014) High-Density Lipoprotein: Vascular Protective Effects, Dysfunction, and Potential as Therapeutic Target. Circulation Research, 114, 171-182.
https://doi.org/10.1161/CIRCRESAHA.114.300935
[13]  Ferroni, P., Roselli, M., Riondino, S. and Guadagni, F. (2014) Predictive Value of HDL Cholesterol for Cancer-Associated venous Thromboembolism during Chemotherapy. Journal of Thrombosis and Haemostasis, 12, 2049-2053.
https://doi.org/10.1111/jth.12737
[14]  Zeki, D., G?khan, B., ?eyma, D., et al. (2023) Evaluation of the Relationship between Monocyte to High-Density Lipoprotein Cholesterol Ratio and Thrombus Burden in Patients with Deep Vein Thrombosis. Revista da Associa??o Médica Brasileira, 69, e20221211.
https://doi.org/10.1590/1806-9282.20221211
[15]  Dahlback, B. (2005) Regulation of Blood Coagulation by the Protein C Anticoagulant Pathway: Novel Insights into Structure-Function Relationships and Molecular Recognition. Ar-teriosclerosis, Thrombosis, and Vascular Biology, 25, 1311-1320.
https://doi.org/10.1161/01.ATV.0000168421.13467.82
[16]  Gao, B., Xiao, J.Q., Zhang, M., et al. (2019) High-Density Lipoprotein Cholesterol for the Prediction of Mortality in Cirrhosis with Portal Vein Thrombosis: A Ret-rospective Study. Lipids in Health and Disease, 18, Article 79.
https://doi.org/10.1186/s12944-019-1005-8
[17]  Xu, Z., Dai, X., Yao, Y., et al. (2016) Higher Levels of Serum Triglycerides Were Associated with Postoperative Deep Vein Thrombosis after Total Hip Arthroplasty in Patients with Nontraumatic Osteonecrosis of the Femoral Head. International Journal of Lower Extremity Wounds, 15, 41-44.
https://doi.org/10.1177/1534734615580017
[18]  Doggen, C.J.M. (2004) Serum Lipid Levels and the Risk of Ve-nous Thrombosis. Arteriosclerosis Thrombosis and Vascular Biology, 24, 1970-1975.
https://doi.org/10.1161/01.ATV.0000143134.87051.46
[19]  Brill, A., Yesilaltay, A., Meyer, S.F.D., et al. (2012) Extrahepatic High-Density Lipoprotein Receptor SR-BI and ApoA-I Protect against Deep Vein Thrombosis in Mice. Ar-teriosclerosis Thrombosis & Vascular Biology, 32, 1841-1847.
https://doi.org/10.1161/ATVBAHA.112.252130
[20]  Rajagopal, G., Suresh, V. and Sachan, A. (2012) High-Density Lipoprotein Cholesterol: How High. Indian Journal of Endocrinology and Metabolism, 16, S236-S238.
https://doi.org/10.4103/2230-8210.104048
[21]  Florvall, G. and Larsson, B.A. (2006) Apolipoprotein A1 Is a Stronger Prognostic Marker than Are HDL and LDL Cholesterol for Cardiovascular Disease and Mortality in Elderly Men. The Journals of Gerontology: Series A, 61, 1262-1266.
https://doi.org/10.1093/gerona/61.12.1262
[22]  Park, H., Chang, Y., Lee, H., et al. (2023) Association of Total Cholesterol Variability with Risk of Venous Thromboembo-lism: A Nationwide Cohort Study. PLOS ONE, 18, e0289743.
https://doi.org/10.1371/journal.pone.0289743

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133